Uroplasty, Inc. (UPI) Files Registration for $10M Equity Offering
Uroplasty, Inc. (AMEX: UPI) today announced it has filed a registration statement with the SEC in regards to a proposed public offering of $10 million of its common stock. Craig-Hallum Capital Group and Noble International Investments, Inc will act as underwriters in connection with this proposed public offering.
Uroplasty, Inc. (Uroplasty) is a medical device company that develops, manufactures and markets products for the treatment of voiding dysfunctions. Uroplasty’s products treat urinary and fecal incontinence and overactive bladder symptoms. It offers a diverse set of products to address the various preferences of doctors and patients
Create E-mail AlertRelated Categories
Equity OfferingsStocks Mentioned
-0.05Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
